Stem cell therapy in Bangkok for Australian patients at MRC Healthcare

    For patients travelling from Australia

    Stem Cell Therapy in Thailand for Australian Patients

    Australia's autologous and allogeneic cell therapy rules mean most mesenchymal stem cell protocols sit inside clinical trials or compassionate access, and advertising of them to the public is restricted. That is the single biggest reason Australians look to Bangkok. This page covers what treatment in Thailand actually involves for someone flying from Sydney, Melbourne, Brisbane, Perth or Adelaide.

    Request a remote consultationRead the full Thailand guide

    In short: stem cell therapy in Thailand for Australian patients

    Australian patients can access mesenchymal stem cell, exosome and IV protocols in Bangkok that are largely limited to clinical trials at home. Assessment happens remotely before you fly, treatment usually takes five to seven days in Bangkok, and follow-up calls are scheduled in AEST/AWST.

    Every protocol is prescribed and supervised by licensed Thai physicians and the cells are processed in our own GMP-aligned, ISO 9001 laboratory in Bangkok. We do not publish prices online because dosing and protocol length depend on your assessment.

    Travel

    Getting to Bangkok from Australia

    Flights

    • Sydney to Bangkok: Direct, roughly 9 hours 30 minutes
    • Melbourne to Bangkok: Direct, roughly 9 hours 45 minutes
    • Brisbane to Bangkok: Direct, roughly 9 hours
    • Perth to Bangkok: Direct, roughly 7 hours

    Time difference

    Bangkok is 3 hours behind AEST and 1 hour behind AWST, so consultations sit comfortably inside an Australian working day.

    Entry

    Australian passport holders do not need a visa in advance for short tourist stays in Thailand.

    When to come

    November to February is the driest and coolest window in Bangkok, which most patients prefer for a treatment trip.

    Why Australian patients travel to Thailand for stem cell therapy

    In Australia, cell and tissue products are regulated by the Therapeutic Goods Administration, and most allogeneic mesenchymal stem cell treatments are available only through registered clinical trials or special access pathways. Patients who do not meet trial criteria often have no route to treatment at home.

    Thailand regulates cell therapy through the Ministry of Public Health: it must be prescribed by licensed physicians and delivered in a licensed facility. That gives Australians a clinical setting with a documented process, rather than an unregulated grey market.

    Distance also matters less than people expect. Bangkok is a single overnight flight from the east coast and shorter than a trip to Europe or North America, which is why Thailand is usually the practical choice over Japan, Mexico or Panama.

    Planning a treatment trip from Australia

    Most Australian patients spend seven to nine days in Bangkok: a day to arrive and settle, an assessment day, two to three treatment days, a review day and a buffer before flying home. Sessions are day-care procedures, so you stay in a hotel rather than the facility.

    We complete the medical review before you book flights. If your imaging, bloodwork or history shows treatment is not appropriate, you will hear that in the consultation rather than after you land.

    Travel insurance sold in Australia generally excludes planned overseas treatment, so read the medical-travel exclusions in your policy and ask about cover for the flight and the non-treatment part of the trip.

    Follow-up once you are back in Australia

    You leave with a written clinical summary suitable for your GP or specialist, listing the cell type, dose, batch testing and any supportive protocol.

    Remote follow-up consultations are typically scheduled at one, three and six months, booked in AEST, ACST or AWST rather than Bangkok time. Our team is reachable on WhatsApp and email in between.

    Treatments available in Bangkok

    Australian patients are most often treated with MSC therapy, exosome therapy, NAD+ IV therapy, NK cell therapy and PRP, for conditions including joint pain and osteoarthritis, autoimmune conditions, diabetes and metabolic health and longevity and anti-aging. The international patient guide covers the full treatment timeline and laboratory standards.

    FAQ

    Questions from Australian patients

    Cell and tissue therapies are regulated in Australia by the Therapeutic Goods Administration. Some autologous procedures are permitted under strict conditions, while most allogeneic mesenchymal stem cell treatments are available only through registered clinical trials or special access schemes. That is why many Australian patients look overseas. This is general information, not legal or medical advice about your own case.

    Plan on seven to nine days door to door. The clinical part is usually five to seven days, including assessment, treatment sessions and a final review. We confirm your exact schedule during the remote consultation so you can book flights with confidence.

    Yes. You can send your specialist's letters and imaging with your enquiry, and we provide a written summary at discharge that your GP or specialist can read and act on. We are happy to answer written questions from your treating doctor.

    No. Medicare does not cover elective treatment received overseas, and Australian private health funds do not usually reimburse planned overseas cell therapy. Patients should treat it as a self-funded medical trip and check their travel policy separately.

    Travelling from somewhere else?

    Singapore

    Patient guide for Singaporean patients

    Europe

    Patient guide for European patients

    United States

    Patient guide for American patients

    Canada

    Patient guide for Canadian patients

    Start with a remote consultation

    Send your history and recent imaging or labs. Our physicians will tell you whether treatment is appropriate before you plan any travel.

    Contact MRC HealthcareAbout our doctors & lab